海角破解版

Modeling Alzheimer's risk using human TREM2-knockout microglia

Amanda McQuade from Dr. Mathew Blurton-Jones鈥檚 lab discusses her protocol for differentiating microglia from induced pluripotent stem cells (iPSCs) and the use of these microglia in vivo and in vitro to uncover the mechanisms of immune activation and neurodegeneration in Alzheimer鈥檚 disease.

Amanda McQuade from Dr. Mathew Blurton-Jones鈥檚 lab discusses her protocol for differentiating microglia from induced pluripotent stem cells (iPSCs) and the use of these microglia in vivo and in vitro to uncover the mechanisms of immune activation and neurodegeneration in Alzheimer鈥檚 disease. Based on the 2020 Nature Communications paper ""
Publish Date: February 11, 2021